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Abstract 
Haemophilus parasuis is part of the microbiota of the upper respiratory tract in swine. However, virulent strains can 
cause a systemic disease known as Glässer’s disease. Several virulence factors have been described in H. parasuis 
including the virulence‑associated trimeric autotransporters (VtaAs). VtaA2 is up‑regulated during infection and is 
only found in virulent strains. In order to determine its biological function, the vtaA2 gene was cloned with its native 
promotor region in pACYC184, and the transformed Escherichia coli was used to perform functional in vitro assays. 
VtaA2 was found to have a role in attachment to plastic, mucin, BSA, fibronectin and collagen. As other VtaAs from 
H. parasuis, the passenger domain of VtaA2 contains collagen domains. In order to examine the contribution of the 
collagen repeats to VtaA2 function, a recombinant vtaA2 without the central collagen domains was obtained and 
named vtaA2OL. VtaA2OL showed similar capacity than VtaA2 to adhere to plastic, mucin, BSA, fibronectin and plasma 
but a reduced capacity to adhere to collagen, suggesting that the collagen domains of VtaA2 are involved in collagen 
attachment. No function in cell adhesion and invasion to epithelial alveolar cell line A549 or unspecific binding to pri‑
mary alveolar macrophages was found. Likewise VtaA2 had no role in serum or phagocytosis resistance. We propose 
that VtaA2 mediates adherence to the host by binding to the mucin, found in the upper respiratory tract mucus, and 
to the extracellular matrix proteins, present in the connective tissue of systemic sites, such as the serosa.
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and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
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Introduction
Haemophilus parasuis is a Gram-negative bacterium of 
the Pasteurellaceae family. It is an early colonizer of the 
upper respiratory tract and part of the normal microbiota 
of healthy pigs [1]. Under certain circumstances, viru-
lent strains of H. parasuis can produce Glässer’s disease, 
which is characterized by fibrinous polyserositis, includ-
ing arthritis, and meningitis [2]. Glässer’s disease repre-
sents a big economic burden for the pig industry [3] and 
prevention and control continue to be challenging since 
the pathogenicity of H. parasuis is not fully characterized.
Comparison between virulent and non-virulent strains 
allowed the description of some mechanisms of the 
pathogenesis of H. parasuis. Strains of H. parasuis dis-
play mechanisms for mucosal colonization by adhering 
and invading epithelial and endothelial cells [4–6]. H. 
parasuis virulence is associated to evasion of the innate 
immune system by degradation of IgA [7], resistance to 
phagocytosis by alveolar macrophages [8] and resistance 
to serum complement killing [9]. Thus, H. parasuis is 
able to reach internal organs, where it replicates in ser-
osal surfaces. Presence of systemic bacteria produces a 
strong inflammation in the host [10]. Massive fibrin exu-
dates, increased permeability by disruption of adherens 
junctions, invasion of endothelial cells, and unbalanced 
inflammatory response are probably key steps in the 
development of systemic disease, which causes the char-
acteristic lesions of Glässer’s disease, including meningi-
tis [10–13].
Antimicrobial treatment remains useful to control 
Glässer’s disease at the farm level. However, the rise of 
antimicrobial resistances is a serious threat to animal and 
public health. Global efforts have been adopted to reduce 
the use of antibiotics in veterinary medicine. Besides, the 
use of antimicrobials may affect the colonization by H. 
parasuis and modify disease dynamics and the develop-
ment of immune responses [14–16], which may finally 
affect the immunocompetence of the host.
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Virulence-associated trimeric autotransporters 
(VtaA) are surface exposed proteins of the Type V 
secretion system involved in host–pathogen interac-
tion [17, 18] and promising vaccine candidates [19]. 
Trimeric autotransporters are composed of an N‐termi-
nal signal peptide for transport across the inner mem-
brane; a C‐terminal translocator domain that creates a 
pore with a β‐barrel structure in the outer membrane; 
and a passenger domain that is secreted to the bacterial 
surface [20]. The passenger domains of all the VtaAs 
possess motifs and repeats characteristic of adhesins, 
hemagglutinins and invasins, with various centrally 
located copies of triple helix collagen-like repeats [17]. 
Virulent H. parasuis strains have several copies of vtaA 
in their genome and some of them have been found to 
be immunogens [17, 21], demonstrating that these pro-
teins are expressed during infection, and supporting 
their role in infection. Some vtaAs have been associated 
specifically to virulent strains [17, 22, 23], but so far a 
function has been assigned only to VtaA8 and VtaA9, 
with a role in phagocytosis resistance [18]. Through 
transcriptomic studies, vtaA8 and vtaA9 (together with 
other vtaA) were found to be up-regulated during lung 
infection [24]. Likewise, up-regulation of vtaA2 tran-
scription in lung was detected after 2  h and after 1, 2 
and 3 days post-infection [24], indicating that VtaA2 is 
involved in for lung infection.
VtaA2 comprises 1225 amino acids and presents a 
slightly different structure compared to VtaA8 and 
VtaA9. Although they display the same basic structure, 
the number of LbR-YadA-like repeats and specially the 
number of collagen repeats differ between VtaA2 and 
those found in VtaA8 or 9 [17, 25], suggesting a differ-
ent function.
In the present study, we evaluated the function of 
VtaA2 by cloning vtaA2 from the virulent strain Naga-
saki of H. parasuis with its native promotor in an E. 
coli background. In  vitro assays showed that VtaA2 
has adhesion features that could be important for host 
infection.
Materials and methods
Bacterial strains and plasmids
Plasmids used in this work are indicated in Table 1. Plas-
mid pACYC184 is a low copy number vector, at about 15 
copies per cell, and contains the p15A origin of replica-
tion. The unique BamHI site in the plasmid was used as 
cloning site.
Escherichia coli BL21 (DE3) was used as the host for 
recombinant plasmids and was grown in Luria–Bertani 
(LB) medium, supplemented with 30  µg/mL chloram-
phenicol (Cm30).
Cloning of vtaA2 and protein expression
A fosmid genomic library of H. parasuis virulent strain 
Nagasaki previously produced [18] was used for vtaA2 
amplification. In order to detect clones containing 
the individual vtaA genes, a specific PCR previously 
described was used [23]. To identify fosmids carrying 
vtaA2, a PCR to detect a vtaA2 fragment was performed 
with primers HPNK_01698_F and HPNK_01698_R 
(Nagasaki genome number ANKT01000000; Table  2) 
[24]. Gene vtaA2 was detected in 2 fosmids and one of 
them was used as template to PCR-amplify vtaA2 with 
primers BamHI-vtaAF and BamHI-vtaAR [18] and 
Platinum™SuperFI™ DNA polymerase (Invitrogen, Bar-
celona, Spain) (Table  2). Amplicon size was confirmed 
and the product cloned into pACYC184 to produce 
pLGR-vtaA2. Plasmid pLGR-vtaA2 was introduced in 
electrocompetent E. coli BL21 (DE3).
In order to determine the role of the collagen-like 
repeats present in the passenger domain of VtaA2, a 
recombinant VtaA2 without the central protein frag-
ment containing the collagen domains was produced. 
The 5′ terminus and 3′ terminus of the gene were ampli-
fied from the fosmid containing the vtaA2 with overlap-
ping primers (Table  2). The PCR fragment containing 
the promoter region and nucleotides 1 to 1050 of vtaA2 
Table 1 Plasmids used in this work and their main 
characteristics 
Cm: chloramphenicol, Tet: tetracycline, Am: ampicillin, R: resistant.
Plasmids Description Reference
pACYC184 low copy number, CmR, TetR, 
4245 bp
ATCC number 37033
pLGR‑vtaA2 pACYC184 with a 4016 bp insert, 
including vtaA2 and its promo‑
tor region
This work
pLGR‑vtaA2OL pACYC184 with a 2514 bp insert, 
including vtaA2OL and the 
promotor region of vtaA2
This work
pEGFP gfp, AmR Clontech
Table 2 Primers used in PCR in this work 
a BamHI site in primers is underlined.
Primer Primer sequence (5′–3′)
HPNK_01698_F GGA GTC ATG CTC AAC AGG CT
HPNK_01698_R CAG CCT CTT CCT TCC TTC CG
BamHI‑vtaAFa GCGC GGA TCC TCT TAG TTT TGT GTA ACT CTTG 
BamHI‑vtaARa GCGC GGA TCC TTC TAA TTT ATA GGT GCT AGA TTA C
OL‑vtaA2F TGG CGA TCT AGG ACC TAC GGG TCC AAC GGG AC
OL‑vtaA2R CCG TAG GTC CTA GAT CGC CAT TTA GTT CAT T
vtaA2‑865F AGC AGT GGC AAG GTA GGC 
vtaA2‑2655R CTC CAT CGG TAA ACC GCT G
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(amplified with BamHI-vtaAF and OL-vtaA2R) and 
the second fragment containing nucleotides 2551 to 
3678 of the vtaA2 gene (amplified with OL-vtaA2F and 
BamHI-vtaAR) were purified and ligated, yielding pLGR-
vtaA2OL. To confirm that the two gene fragments were 
in-frame, primers vtaA2-865F and vtaA2-2655R (down-
stream and upstream of the deleted gene section, Table 2) 
were used for sequencing.
Expression of the corresponding protein was assessed 
in the clones. E. coli BL21 containing pLGR-vtaA2 or 
pLGR-vtaA2OL were grown in LB-Cm30 up to late-loga-
rithmic phase. Bacteria were pelleted and protein extrac-
tion was performed with TRIzol™ Reagent (Invitrogen) 
according to the manufacturer’s instructions. Protein 
extracts were quantified by the BCA protein assay kit 
(Pierce-Thermo Fisher Scientific, Sant Cugat del Vallès, 
Spain), loaded in a  NuPAGE® Novex 4–12% Bis–Tris 
Gel, followed by a transfer to a Hybond™ ECL™ nitro-
cellulose membrane (GE Healthcare, Barcelona, Spain). 
After blocking with 1% casein 0.05% Tween20 in PBS, 
membranes were incubated with the monoclonal anti-
body 69C6 [18] at 2 ng/µL in blocking solution. Proteins 
VtaA2 and its truncated version VtaA2OL were detected 
by chemiluminescence after incubation with peroxidase-
conjugated goat anti-mouse immunoglobulin (Sigma-
Aldrich, Madrid, Spain) diluted 1:10 000.
Attachment assays
The role of VtaA2 in attachment was evaluated on plastic 
and on different protein substrates. Various time points 
(6 h, 12 h, 24 h, 48 h) were tested under static or shacking 
conditions. Attachment assays were performed in 96-well 
plates and attachment was measured by crystal violet 
staining as previously described with some modifications 
[26]. First, flat-bottom 96-well polystyrene plates (SPL, 
Life Sciences, Naechon- Myeon, Korea) were coated with 
200 µL of 25  µg/mL mucin (Sigma Aldrich), fibronec-
tin (Invitrogen) or collagen (type I, Sigma Aldrich) in 
carbonate-bicarbonate buffer (pH 9.6) in triplicate. Por-
cine plasma was also used. Plasma was obtained by cen-
trifugation of heparinized blood from a healthy animal 
and used for coating at 1:2 or 1:10 dilution. Sampling 
was performed under institutional authorization and 
followed good veterinary practices. According to Euro-
pean (Directive 2010/63/EU) and Spanish (Real Decreto 
53/2013) normative, this procedure did not require spe-
cific approval by an Ethical Committee. Bovine serum 
albumin (BSA; Sigma Aldrich) was used as non-specific 
protein control and some wells remained uncoated. After 
overnight incubation at 4  °C, wells were washed once 
with sterile PBS. Bacterial suspensions were prepared 
in PBS  (OD600 of 0.3) using overnight agar cultures on 
LB-Cm30 of E. coli BL21 pACYC184 (negative control), 
pLGR-vtaA2 and pLGR-vtaA2OL. Bacterial suspensions 
were diluted down 1:100 in fresh LB broth with Cm30 
and were used to inoculate wells in triplicate (100 µL/
well).
Plates were incubated in static conditions or under 
shaking (100 rpm) for different time-points (3 h, 6 h, 12 h 
and 24 h). After incubation, plates were washed once by 
water immersion and attached bacteria were stained with 
0.1% (w/v) crystal violet for 2 min. After three washes in 
water by immersion, plates were allowed to dry at 42 °C. 
Stain in the wells was solubilized with 70% ethanol and 
the released dye was quantified by measuring the absorb-
ance at 590  nm with a microplate reader (Power Wave 
HT Microplate Spectrophotometer, BioTek, Winooski, 
USA).
Cellular adhesion and invasion assays
Epithelial cell line A549 from human lung carcinoma 
(ATCC ® CCL-185™) was used for cell adhesion and inva-
sion experiments. Cells were seeded in 96-well plates 
(SPL, Life Sciences) at a concentration of 6 × 104 cells/
well in Dulbecco’s modified Eagle’s medium (DMEM; 
Hyclone GE Healthcare) supplemented with 10% fetal 
bovine serum (FBS) and 1% l-glutamine; complete 
DMEM (CDMEM). Plates were incubated overnight at 
37 °C with 5%  CO2.
Bacterial suspensions of E. coli BL21 pACYC184 and 
E. coli BL21 pLGR-vtaA2 were prepared to reach an 
 OD600 of 0.3 (Spectrophotometer VIS7200), which corre-
sponded approximately to  108 CFU/mL. Protein expres-
sion under conditions was confirmed by immunoblot as 
described above. Bacterial concentration was confirmed 
by serial dilution and plating. Duplicate wells with epi-
thelial cells were inoculated with 100 µL of each bacterial 
suspension and plates were incubated at 37  °C with 5% 
 CO2 for 1  h. After incubation, wells were washed three 
times with PBS to eliminate unbound bacteria. To release 
bacteria, epithelial cells in each well were lysed with 100 
µL of sterile Milli-Q water and scrapped. Bacteria were 
counted by plating serial dilution of the lysates. This assay 
was performed twice.
To test cell invasion, the adhesion assay was performed 
as above for adhesion but with an additional step after the 
1 h incubation to allow bacteria to invade the cells. The 
additional step consisted of 2 h incubation with 5 µg/mL 
penicillin G and 100  µg/mL gentamicin to kill extracel-
lular bacteria. After washes, cells were lysed and bacteria 
were counted as in the standard adhesion procedure.
Interaction with porcine alveolar macrophages (PAMs)
The ability of the E. coli clone carrying VtaA2 to attach to 
PAMs was also tested. All procedures involving animals 
followed EU and Spanish normative (Directive 2010/63/
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EU and Real Decreto 53/2013). PAMs were collected 
from bronchoalveolar fluid lavages from healthy pigs 
that were euthanized for this purpose following good 
veterinary practices. According to European (Directive 
2010/63/) and Spanish (Real Decreto 53/2013) norma-
tive, this procedure did not require specific approval by 
an ethical committee. PAMs were isolated and stored at 
−150 °C following standard procedure [8].
Cell adhesion assays to PAMS were performed on ice 
to avoid active phagocytosis. Cells were thawed, gently 
washed of cryopreservant and seeded in 96-well plates at 
a concentration of 5 × 105 cells per well. Plates were incu-
bated at 37 °C with 5%  CO2 overnight to allow the attach-
ment of the cells to the wells. Bacterial suspensions were 
made in CDMEM  (OD600 of 0.3) and 100 µL of these sus-
pensions were used to inoculate triplicate wells. After a 
centrifugation during 10 min at 100 × g plates were incu-
bated on ice for 1 h. Bacterial concentration in the initial 
inoculum was confirmed by dilution and plating. After 
incubation, PAMs were washed three times with PBS to 
eliminate unbound bacteria, and 100 µL of 0.1% saponin 
(Sigma Aldrich) in PBS was added to the wells to lyse the 
PAMs. Serial dilutions were plated in LB agar-Cm30. The 
assay was repeated three independent times.
Phagocytosis assays were performed as described 
before [8]. PAMs were seeded in 6-well plates at a con-
centration of 5 × 105 PAMs/well in CDMEM. After 
incubation to allow attachment of the PAMs, (overnight 
incubation) wells were inoculated with bacteria at a mul-
tiplicity of infection (MOI) of 200. E. coli clones were 
labelled using different strategies to ensure consistent 
fluorescence of all the bacterial population, using fluo-
rescein isothiocyanate (FITC), SYTO9 green fluorescent 
nucleic acid stain (Thermo Fisher Scientific) or transfor-
mation with pEGFP (plasmid carrying the green fluores-
cent protein [GFP] gene; Table  1). After incubation at 
37 °C for different times, wells were washed to eliminate 
unbound bacteria and PAMs with associated bacteria 
were detected by flow cytometry in a MACS Miltenyi 
cytometer (MILTENYI Biotec, Madrid, Spain). Assays 
were performed in duplicate and were repeated using 
PAM from different animals.
Serum resistance assay
To test if VtaA2 was involved in serum resistance, an 
in  vitro assay with rabbit serum was performed as 
described before [9] with some modifications. Briefly, 
overnight colonies of E. coli BL21 (pACYC184) and E. 
coli BL21 (pLGR-vtaA2) were used to prepare bacterial 
suspensions. Bacteria and serum were mixed in 96 well 
plates to give a final quantity of bacteria in the wells of 
 105–106 CFU and a final concentration of 50% serum. 
Mixtures were incubated at 37  °C for 30  min and 1  h. 
Tenfold serial dilutions of each well were made before 
and after incubation, and bacteria were quantified by 
plating onto LB-Cm30. The counts of viable bacteria 
before and after serum treatment were compared.
Results
VtaA2 is involved in attachment to animal proteins
A fosmid containing vtaA2 was used as template to 
amplify and subsequently clone vtaA2 with its putative 
promotor region in pACYC184, yielding pLGR-vtaA2. E. 
coli BL21 (pLGR-vtaA2) showed a growth in LB-Cm30 
similar to the E. coli with the empty plasmid pACYC184 
(not shown). Compared to the empty plasmid control, 
BL21 (pLGR-vtaA2) exhibited more capacity to attach to 
plastic and to all the purified proteins tested (Figure  1), 
indicating that VtaA2 promoted attachment. Attach-
ment to plastic (Figure 1A), mucin (Figure 1B), collagen 
(Figure 1C), fibronectin (Figure 1D) and BSA (Figure 1E) 
by the vtaA2 clone was detected as soon as 6 h of incu-
bation. However, no attachment to swine plasma was 
observed, indicating no ability of VtaA2 to bind to plasma 
components (Figure 1F).
Collagen domains of VtaA2 are involved in collagen 
attachment
To examine the role of the collagen domains of VtaA2 in 
the attachment observed, a truncated version of vtaA2 
lacking the central portion of the gene that encoded 
the collagen domains was cloned in pACYC184 to yield 
pLGR-vtaA2OL. Similarly, BL21 (pLGR-vtaA2OL) dis-
played comparable level of attachment to plastic, mucin, 
fibronectin and BSA than the E. coli with the complete 
vtaA2 (Figure 1). However, a reduction in the attachment 
to collagen was observed in the truncated VtaA2OL (Fig-
ure  1C), indicating that the collagen domains of VtaA2 
may play a role in attachment to collagen through colla-
gen-collagen interaction.
VtaA2 does not promotes cell adhesion or invasion
To explore if VtaA2 could play a role in adhesion to epi-
thelial cells, an assay with the pulmonar epithelial cell 
line A549 was performed. After 1  h of incubation to 
allow the attachment of the bacteria to the cells, no dif-
ferences were observed between the control E. coli BL21 
(pACYC184) and the clone carrying vtaA2 (Figure  2), 
indicating that VtaA2 does not have a direct effect on 
bacterial adhesion to epithelial cells. In agreement with 
the lack of effect on cell adhesion, we did not detect a role 
of VtaA2 in cellular invasion (not shown). In fact, nei-
ther BL21 (pACYC184) nor BL21 pLGR-vtaA2 were able 
to invade epithelial A549 cells, and internalized bacteria 
were not detected in any of the cases.
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VtaA2 does not play a role in the interaction with porcine 
alveolar macrophages (PAMs)
Assays to evaluate the role of VtaA2 in phagocytosis 
resistance were performed. Unfortunately, fluorescent 
labelling of E. coli BL21 (pLGR-vtaA2) and the control 
E. coli was challenging due to differences in staining 
between them. On one hand, BL21 (pLGR-vtaA2) trans-
formed with pEGFP did not consistently express GFP, 
unlike the empty plasmid control, making this labelling 
inadequate for this study. On the other hand, FITC did 
not label properly the control BL21 (pACYC184), and 
5 times more compound was needed to reach similar 
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Figure 1 Kinetics of attachment to different substrates of E. coli clones expressing VtaA2 and VtaA2OL. Wells were coated with mucin (B), 
collagen (C), fibronectin (D), BSA (E), or plasma (F), or were left uncoated (plastic A). Plates were inoculated and incubated under static conditions. 
Attachment was measured at different time points. Black circles: BL21 (pLGR‑vtaA2); red triangles: BL21 (pLGR‑vtaA2OL); and white circles BL21 
(pACY184) (control). Bars represent the standard deviation of the mean  Abs590 from triplicate wells.
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fluorescence intensity than the BL21 expressing VtaA2. 
When FITC-labelled bacteria were used, similar asso-
ciation with PAMs was observed in the vtaA2 clone 
and the control (Figure 3). To confirm these results, the 
nucleic acid stain SYTO9 was used to label the bacteria. 
Equivalent mean of fluorescence intensity in the bacte-
ria was obtained with this dye (BL21 control: 12.9; BL21 
with vtaA2: 10.63). Again, the percentage of PAMs 
associated with the fluorescent vtaA2 clone was simi-
lar to the percentage of PAMs with the control bacteria 
(Figure 4), indicating that VtaA2 does not play a role in 
phagocytosis.
Additionally, attachment to PAMs was examined by 
incubation of the clones with PAMs on ice during 1 h. 
High levels of attachment to the surface of PAMs were 
found and no differences were detected in E. coli BL21 
(pLGR-vtaA2) and the empty plasmid control (not 
shown), indicating that VtaA2 does not to play a role in 
adhesion to macrophages.
VtaA2 is not involved in serum resistance
Both BL21 (pACYC184) and BL21 (pLGR-vtaA2) 
showed similar survival rate after incubation with rab-
bit serum. A reduction of 5 log was observed for both 
clones after 30 min of incubation with 50% serum, and 
no recovery of live bacteria was detected after 1  h of 
incubation (not shown). Therefore, this suggests that 
VtaA2 has no effect on evasion of killing by serum 
complement.
Expression of VtaA2 and VtaA2OL
Proteins of approximately the expected sizes of VtaA2 
(120.99  kDa) and VtaA2OL (75.61  kDa) were detected 
in the bacterial pellet of the corresponding clones 
grown under the conditions used in the functional 
assays (Figure 5), confirming that the lack of phenotype 
found in cell adhesion, invasion or phagocytosis were 
not due to the lack of protein production.
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Figure 2 VtaA2 has no role in the adhesion to lung epithelial 
cells A549 cells. Adhesion of the clones E. coli BL21 (pLGR‑vtaA2) 
and (pACYC184) to lung epithelial cells A549 after 1 h of incubation 
(black bars). Concentration of bacteria in the wells at the beginning of 
the assay are shown in gray bars. Bars represent the mean ± standard 
deviation of the concentration of bacteria from duplicate wells. 
Results are representative of 2 independent experiments.
Figure 3 VtaA2 has no role in the bacterial interaction with 
PAMs; bacteria stained with FITC. E. coli BL21 clones (pLGR‑vtaA2; 
dark grey bars) and empty vector pACYC184 (black bars) were stained 
with FITC, incubated for 1 h or 3 h with PAMs and the interaction 
with the macrophages was analyzed by flow cytometry. Results are 
shown as the percentage of fluorescent macrophages. Macrophages 
without bacteria were included as negative (light grey bars). Bars 
represent the mean ± standard deviation.
Figure 4 VtaA2 has no role in the bacterial interaction 
with PAMs; bacteria stained with SYTO9. E. coli BL21 clones 
(pLGR‑vtaA2; dark grey bars) and empty vector pACYC184 (black 
bars) were stained with SYTO9, incubated for 1 h with PAMs and the 
interaction with the macrophages was analyzed by flow cytometry. 
Results are shown as the percentage of fluorescent macrophages. 
Macrophages without bacteria were included as negative (light grey 
bars). Bars represent the mean ± standard deviation.
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Discussion
Bacterial pathogens adhere to epithelial cells or host pro-
teins in order to prevent clearance by the host. Adhesion 
is achieved by adhesins, which are bacterial surface struc-
tures that confer ability to bind to surrounding cells, pro-
teins or tissues. Virulent strains of H. parasuis have the 
ability to overcome the host clearing system, and after 
an initial colonization of the upper respiratory tract, can 
reach the lower respiratory tract, multiply and spread 
systemically [27]. However, how H. parasuis infection 
is established at systemic sites is not fully understood 
yet. Some VtaAs, including VtaA2, are associated with 
virulent strains of H. parasuis [17]. The involvement of 
VtaA2 in H. parasuis virulence was supported by its up-
regulation during lung infection [24], but until now no 
specific function was assigned to this protein. Here we 
have shown that VtaA2 is able to promote attachment to 
several host molecules in a time-dependent manner. The 
ability of VtaA2 to bind to mucin could be an indication 
of the role of this protein in the initial attachment to the 
upper respiratory tract. Later, in the lung, VtaA2 could 
still promote attachment, while VtaA8 and VtaA9, which 
are also up-regulated during lung infection [24], would 
participate in phagocytosis resistance [18]. In addition, 
the capacity of VtaA2 to bind to ECM molecules suggest 
that VtaA2 is also important once H. parasuis spreads to 
internal organs. Therefore, we could hypothesize a dual 
role of VtaA2 in H. parasuis pathogenesis, in the initial 
colonization of the respiratory tract and in the posterior 
invasive infection.
Mucin is the major structural component of mucosa 
secretion that overlays the upper respiratory tract of 
swine. Mucins are a family of heavily O-glycosylated 
proteins that are the major organic components of the 
mucus layer, the protective layer covering the epithelial 
cells in many human and animal organs [28]. Pathogens 
that infect mucosal surfaces share two main goals: (1) 
to overcome the mucus barrier and (2) to interact with 
the underlying epithelial cells and cause disease [29]. 
Mucus layers consist mainly of gel-forming mucin-type 
glycoproteins [28]. Most mucins have a high sialic acid 
content. Interestingly, systemic isolates of H. parasuis 
present the sialyltransferase-encoding gene lsgB gene, 
which is involved in the terminal sialylation of the lipoo-
ligosacharide (LOS), with roles in host cell adhesion and 
serum resistance [30, 31]. LOS sialylation is a molecu-
lar mimicry mechanism extensively used by bacteria to 
evade the host immune system. We could hypothesize 
that, by binding to mucin through VtaA2, H. parasuis 
could enhance its interaction to mucin, facilitating LOS 
sialyation by using mucin as source of sialic acid, and pro-
moting H. parasuis virulence. In addition, prior infection 
of piglets by Bordetella bronchiseptica, which induces an 
accumulation of mucus [32], results in an increased colo-
nization by H. parasuis [33]. VtaA2 could play a key role 
in such scenario by promoting attachment to mucin in 
the abundant mucus.
Inflammatory responses due to multiple pathogens can 
disrupt the mucus layer and cause epithelial damage in the 
airway mucosa, allowing access to intruding bacteria to the 
underlying epithelium and to ECM proteins, and explain-
ing the exacerbation of clinical signs [34, 35]. Virulent 
strains of H. parasuis can be detected in pig lung, nasal tur-
binates, trachea including the submucosa [36], indicating 
that, as other respiratory pathogens, H. parasuis may have 
the capacity to bind and degrade ECM proteins in order 
to adhere to and invade host tissues [37]. Collagens are 
the most abundant proteins in the lung ECM [38]. Colla-
gen can be associate with cartilage, including trachea, pre-
sent in the connective tissues or as part of the basal lamina 
that anchors epithelial cells to the mesenchyme [39]. The 
attachment of the host cells to components of the ECM, 
such as collagen, is also mediated by fibronectin [40]. Mul-
tiple bacterial fibronectin and collagen binding proteins 
have been described, including trimeric autotransporters 
Figure 5 VtaA2 and VtA2OL are produced under in vitro 
conditions. Detection by immunoblot of VtaA2 and its truncated 
version VtaA2OL from E. coli BL21 (pLGR‑vtaA2) and E. coli BL21 
(pLGR‑vtaA2OL) respectively. Both proteins were extracted from 
bacterial pellets grown in LB‑Cm30 or incubated with CDMEM. 
Molecular size standards in kDa are shown on the left. Protein 
extraction from E. coli BL21 transformed with pACYC184 empty 
plasmid was used as negative control of expression.
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[41–43]. Therefore, expression of the trimeric autotrans-
porter VtaA2 in the bacterial surface could be a key factor 
for Glässer’s disease progress by attachment to both colla-
gen and fibronectin.
Interestingly, VtaA2OL showed a reduced capacity to 
bind to collagen, suggesting that the loss of these collagen 
domains in VtaA2 are essential for collagen attachment, by 
collagen-collagen interaction. On the other hand, VtaA2 
includes other binding domains to host molecules since the 
attachment to other proteins, such as mucin or fibronectin, 
is not affected when the collagens domains were removed. 
In fact, other domains with adhesion function previously 
described in VtaAs [17] are characteristic of cell surface 
adhesion molecules from other pathogenic bacteria [44, 
45]. Further characterization of the VtaA2 structure would 
be needed to elucidate other functional domains, confor-
mational structures or other factors that can affect the 
binding affinity for host receptors.
With the dramatic rise of antimicrobial resistances and 
the corresponding threat to human and animal health, it is 
crucial to find alternative approaches to block the ability of 
bacteria, such as H. parasuis, to cause disease at the early 
stages of infection with the design, for instance, of anti-
adhesion vaccines.
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